FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1335-1336 April 26, 2001 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Jordan Goodman and Vivien Walsh. 282 pp. New York, Cambridge University Press, 2001. $27.95. ISBN 0-521-56123-X.

For anyone wanting all the details of the development of paclitaxel (Taxol) from its very beginning until it was marketed as a new, natural-product anticancer drug, this book is an excellent source of information. It is carefully researched and detailed, and as someone who was at the National Cancer Institute (NCI) during part of the development of Taxol, I found it factually accurate.

In the book, Taxol and the source of Taxol, the bark of the tree Taxus brevifolia, are treated as unique characters in a historical novel. The authors weave the story of the discovery of this drug and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.